dc.contributor.author | Ozkaynakci, Aydan | |
dc.contributor.author | Aker, Rezzan Gulhan | |
dc.contributor.author | GÖREN, MEHMET ZAFER | |
dc.contributor.author | Gulcebi, Medine Idrizoglu | |
dc.contributor.author | Ozkara, Cigdem | |
dc.contributor.author | Onat, Filiz Yilmaz | |
dc.date.accessioned | 2021-03-06T21:13:29Z | |
dc.date.available | 2021-03-06T21:13:29Z | |
dc.identifier.citation | Gulcebi M. I. , Ozkaynakci A., GÖREN M. Z. , Aker R. G. , Ozkara C., Onat F. Y. , "The relationship between UGT1A4 polymorphism and serum concentration of lamotrigine in patients with epilepsy", EPILEPSY RESEARCH, cilt.95, ss.1-8, 2011 | |
dc.identifier.issn | 0920-1211 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_fdb804c7-8b15-445c-a769-1dd16218bbbe | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/165971 | |
dc.identifier.uri | https://doi.org/10.1016/j.eplepsyres.2011.01.016 | |
dc.description.abstract | Lamotrigine (LTG) which has a widespread use in epilepsy treatment as an antiepileptic agent is metabolized by UDP-glucuronosyl transferase (UGT) enzymes. In this study, single nucleotide polymorphisms, P24T and L48V, of the UGT1A4 enzyme have been investigated in a Turkish population of patients with epilepsy (n=131) by comparing serum levels of LTG of wild type and polymorphic subjects. | |
dc.language.iso | eng | |
dc.subject | Nöroloji | |
dc.subject | KLİNİK NEUROLOJİ | |
dc.subject | Klinik Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Tıp | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Dahili Tıp Bilimleri | |
dc.title | The relationship between UGT1A4 polymorphism and serum concentration of lamotrigine in patients with epilepsy | |
dc.type | Makale | |
dc.relation.journal | EPILEPSY RESEARCH | |
dc.contributor.department | Marmara Üniversitesi , , | |
dc.identifier.volume | 95 | |
dc.identifier.startpage | 1 | |
dc.identifier.endpage | 8 | |
dc.contributor.firstauthorID | 29528 | |